GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Other Operating Expense

Novartis India (BOM:500672) Other Operating Expense : ₹725 Mil (TTM As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India Other Operating Expense?

Novartis India's Other Operating Expense for the three months ended in Mar. 2024 was ₹132 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹725 Mil.

Novartis India's quarterly Other Operating Expense increased from Sep. 2023 (₹178 Mil) to Dec. 2023 (₹194 Mil) but then declined from Dec. 2023 (₹194 Mil) to Mar. 2024 (₹132 Mil).

Novartis India's annual Other Operating Expense declined from Mar. 2022 (₹1,452 Mil) to Mar. 2023 (₹833 Mil) and declined from Mar. 2023 (₹833 Mil) to Mar. 2024 (₹724 Mil).


Novartis India Other Operating Expense Historical Data

The historical data trend for Novartis India's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Other Operating Expense Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,622.20 1,549.20 1,452.40 832.60 724.10

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.20 221.00 177.80 193.70 132.10

Novartis India Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹725 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis India Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Novartis India's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines